Why can't I see FountainRx pricing before I quote a patient?

The pricing transparency problem shows up when a patient is ready to start a GLP-1 or hormone protocol and you cannot state the medication cost because pricing waits on insurance verification or prior authorization. You either guess, pad the quote, or promise a follow-up — and follow-ups are where cash-pay conversions stall.

For owners running blended insured and cash-pay programs, the same opacity makes margin planning uncertain. If landed cost is only knowable after FountainRx completes payor review, your P&L for cash-pay lines that never touch insurance still gets modeled from estimates rather than numbers.

FountainRx FAQ explains that prescription cost varies with insurance plan coverage, deductibles, and whether prior authorization is required before a costly medication is covered. Once that process completes, FountainRx notifies the patient about out-of-pocket cost. That is the right model for insured specialty therapies with high-cost drugs and complex payor rules.

It is the wrong default for cash-pay weight-loss, hormone, and peptide clinics that need pass-through 503A cost on each line before checkout. When you evaluate FountainRx for those patients, ask whether cash-pay referrals bypass insurance review and whether per-vial rates appear anywhere prescriber staff can quote from during the visit.

The delay disappears when pricing is visible at the point of decision. Fizy Health shows resolved per-vial 503A cost on each catalog and cart line before checkout, with the facilitation fee disclosed at payment, so a clinician can quote a patient in the room and an owner can model margin from real numbers. There is no payor gate between you and the cost of the medication you are about to order.

Pass-through pricing is the structural difference for cash-pay work: instead of waiting on insurance outcomes, you see the 503A cost and the disclosed fee. Many clinics keep FountainRx for insured specialty lines and add Fizy Health for high-volume cash-pay batch ordering where margin clarity is the bottleneck.